Related Experiment Videos
The effect of dialyzer reprocessing on performance and beta 2-microglobulin removal using polysulfone membranes
R J Diaz1, S Washburn, L Cauble
1Department of Internal Medicine, University of Arizona Health Sciences Center, Tucson 85724.
Summary
Reprocessing polysulfone membrane dialyzers up to 24 uses maintained urea clearance and significantly improved beta 2-microglobulin removal. This suggests dialyzer reprocessing is effective for long-term hemodialysis, enhancing biocompatibility and reducing costs.
Area of Science:
- Nephrology
- Biomaterials Science
- Medical Device Engineering
Background:
- Routine dialyzer reprocessing is favored for increased biocompatibility and lower cost.
- Longer-term reprocessing of polysulfone membranes (PMs) is critical, with concerns about decreased efficiency, especially in beta 2-microglobulin (beta 2M) removal, linked to dialysis-associated amyloidosis (DDA).
Purpose of the Study:
- To evaluate the impact of up to 24 reuses on the performance of polysulfone membrane dialyzers.
- To assess changes in urea clearance (Kd), urea mass transfer coefficient (h0), ultrafiltration coefficient (K(uf)), and beta 2-microglobulin (beta 2M) removal.
Main Methods:
- Eleven hemodialysis patients underwent testing of PMs reprocessed manually with bleach and formaldehyde.
- Dialyzer efficacy was examined at 1, 5, 10, 15, 20, and 24 uses.
- Measurements included Kd, h0, K(uf), and percent removal of beta 2M (corrected for ultrafiltration).
Main Results:
- Urea clearance (Kd) showed no significant change over 24 uses.
- The urea mass transfer coefficient (h0) significantly increased by the 15th use.
- The ultrafiltration coefficient (K(uf)) significantly increased at the 10th and 20th uses (P < 0.05).
- Percent removal of beta 2M significantly increased from 44.1% in the first use to 63.1% by the 24th use (P < 0.001).
Conclusions:
- Polysulfone membrane dialyzers can be effectively reprocessed up to 24 times.
- Reprocessing does not compromise urea clearance and enhances the removal of beta 2-microglobulin.
- This supports the routine reprocessing of dialyzers for long-term hemodialysis, offering cost and biocompatibility benefits.